Works matching IS 11707690 AND DT 2023 AND VI 41 AND IP 5

Results: 9

Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US.

Published in:

PharmacoEconomics, 2023, v. 41, n. 5, p. 605, doi. 10.1007/s40273-023-01263-w

By:

Goswami, Hardik;
Alsumali, Adnan;
Jiang, Yiling;
Schindler, Matthias;
Duke, Elizabeth R.;
Cohen, Joshua;
Briggs, Andrew;
Puenpatom, Amy

Publication type:

Article

Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan.

Published in:

PharmacoEconomics, 2023, v. 41, n. 5, p. 589, doi. 10.1007/s40273-023-01254-x

By:

Kobayashi, Taku;
Hoshi, Masato;
Yuasa, Akira;
Arai, Shoko;
Ikeda, Mitsunobu;
Matsuda, Hiroyuki;
Kim, Seok-Won;
Hibi, Toshifumi

Publication type:

Article

Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella.

Published in:

PharmacoEconomics, 2023, v. 41, n. 5, p. 481, doi. 10.1007/s40273-023-01252-z

By:

Doggen, Kris;
van Hoek, Albert Jan;
Luyten, Jeroen

Publication type:

Article

The Cost of Uncontrolled Blood Pressure in Australian General Practice: A Modelling Study Using Electronic Health Records (MedicineInsight).

Published in:

PharmacoEconomics, 2023, v. 41, n. 5, p. 573, doi. 10.1007/s40273-023-01251-0

By:

Roseleur, Jacqueline;
Gonzalez-Chica, David A.;
Harvey, Gillian;
Stocks, Nigel P.;
Karnon, Jonathan

Publication type:

Article

Economic Analyses of Obsessive-Compulsive Disorder Interventions: A Systematic Review.

Published in:

PharmacoEconomics, 2023, v. 41, n. 5, p. 499, doi. 10.1007/s40273-023-01250-1

By:

Strouphauer, Emily R.;
Morris, Olivia J.;
Soileau, Keaton J.;
Wiese, Andrew D.;
Quast, Troy;
Goodman, Wayne K.;
Sheth, Sameer A.;
Wojcik, Katharine D.;
Guzick, Andrew G.;
Storch, Eric A.

Publication type:

Article

HTA Barriers for Conditional Approval Drugs.

Published in:

PharmacoEconomics, 2023, v. 41, n. 5, p. 529, doi. 10.1007/s40273-023-01248-9

By:

Mills, Mackenzie

Publication type:

Article

How to Predict Drug Expenditure: A Markov Model Approach with Risk Classes.

Published in:

PharmacoEconomics, 2023, v. 41, n. 5, p. 561, doi. 10.1007/s40273-023-01240-3

By:

Hofbauer-Milan, Valeska;
Fetzer, Stefan;
Hagist, Christian

Publication type:

Article

Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A Systematic Literature Review.

Published in:

PharmacoEconomics, 2023, v. 41, n. 5, p. 467, doi. 10.1007/s40273-022-01223-w

By:

Bozzani, Fiammetta M.;
Terris-Prestholt, Fern;
Quaife, Matthew;
Gafos, Mitzy;
Indravudh, Pitchaya P.;
Giddings, Rebecca;
Medley, Graham F.;
Malhotra, Shelly;
Torres-Rueda, Sergio

Publication type:

Article

Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK.

Published in:

PharmacoEconomics, 2023, v. 41, n. 5, p. 547, doi. 10.1007/s40273-022-01219-6

By:

Zhou, Junwen;
Wu, Runguo;
Williams, Claire;
Emberson, Jonathan;
Reith, Christina;
Keech, Anthony;
Robson, John;
Wilkinson, Kenneth;
Armitage, Jane;
Gray, Alastair;
Simes, John;
Baigent, Colin;
Mihaylova, Borislava

Publication type:

Article